Poke Root (Phytolacca americana)

Poke root (Phytolacca americana) contains pokeweed mitogen (PWM), a lectin-type glycoprotein that selectively stimulates T-lymphocyte proliferation and immune signaling in laboratory settings. Its triterpene saponins, particularly phytolaccagenin and esculentoside A, also demonstrate anti-inflammatory and antiviral properties, though clinical human data remain extremely limited and the plant carries serious toxicity risks.

Origin & History

Poke Root derives from the roots of Phytolacca americana, a perennial herbaceous plant native to eastern North America, also naturalized in parts of Europe and Asia. The plant grows up to 3 meters tall with red-purple stems and purple-black berries; roots are typically harvested, dried, and powdered or extracted via decoction or tincture for herbal use. Chemically, it belongs to the triterpenoid saponin class, featuring compounds like phytolaccagenin and lectins such as pokeweed mitogen.

Historical & Cultural Context

In Native American and early European settler traditions (North America, 17th-19th centuries), poke root was used for rheumatism, arthritis, scrofula, and as an emetic or purgative, with ashes applied topically for ulcers and skin cancers due to high potassium content. It features in global folk herbalism for lymphatic swelling and infections, but not prominently in formalized systems like Ayurveda or TCM beyond minor 'Shanglu' references.

Health Benefits

• Immune system stimulation through pokeweed mitogen (PWM), a T-cell mitogen that stimulates lymphocyte proliferation (in vitro evidence only)
• Anti-inflammatory effects via triterpene saponins like phytolaccagenin through potential membrane interactions (preliminary evidence)
• Antiviral activity from pokeweed antiviral protein (PAP) which inhibits protein synthesis in viruses (in vitro evidence only)
• Traditional use for rheumatism and arthritis relief (historical evidence only, no clinical validation)
• Lymphatic support for swelling and infections in folk herbalism (traditional use only, no clinical studies)

How It Works

Pokeweed mitogen (PWM) acts as a T-cell mitogen by binding to carbohydrate residues on lymphocyte surface glycoproteins, triggering polyclonal T-cell and B-cell proliferation and upregulating interleukin-2 (IL-2) production in vitro. The triterpene saponins phytolaccagenin and phytolaccosides disrupt inflammatory signaling by interacting with cell membrane phospholipids and inhibiting cyclooxygenase (COX) enzyme activity, reducing prostaglandin synthesis. Additionally, phytolacca antiviral protein (PAP), a ribosome-inactivating protein (RIP), depurinates 28S ribosomal RNA in virally infected cells, thereby halting viral protein synthesis at the translational level.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on poke root (Phytolacca americana) were identified in the available research. The ingredient appears only as a minor component in homeopathic formulations like Lymphapar and MBM 13, but no specific study designs, sample sizes, or outcomes for poke root alone are documented. Traditional claims for anti-inflammatory or immune effects lack modern clinical validation.

Clinical Summary

Human clinical evidence for poke root is virtually nonexistent; the majority of supporting data derives from in vitro cell studies and animal models, with no randomized controlled trials published as of 2024. In vitro studies using isolated PWM have reliably demonstrated lymphocyte proliferation in human blood samples, establishing a mechanistic basis for immune activity, but this does not translate to safe oral supplementation. Animal studies with PAP-conjugated immunotoxins have shown targeted antiviral and antitumor effects at microgram-per-kilogram doses, primarily in HIV and leukemia research contexts. Historical use in Eclectic medicine was documented anecdotally for lymphatic conditions, but no modern dose-response or safety trials in humans have been conducted, making evidence quality extremely low.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 2.5 grams per 100 grams of fresh leaves", "fiber": "Approximately 3 grams per 100 grams of fresh leaves"}, "micronutrients": {"vitamin_A": "Approximately 800 IU per 100 grams of fresh leaves", "vitamin_C": "Approximately 30 mg per 100 grams of fresh leaves", "calcium": "Approximately 250 mg per 100 grams of fresh leaves", "iron": "Approximately 3 mg per 100 grams of fresh leaves"}, "bioactive_compounds": {"phytolaccagenin": "Present in triterpene saponins, concentration not well-documented", "pokeweed_antiviral_protein": "Concentration not well-documented, primarily studied in vitro"}, "bioavailability_notes": "Nutrients and bioactive compounds may vary based on plant maturity and preparation methods. Cooking is recommended to reduce toxicity."}

Preparation & Dosage

No clinically studied dosage ranges for poke root extracts, powders, or standardized forms are available, as human trials are absent. Standardization details to triterpenoid saponins or pokeweed mitogen are not provided for any studied preparations. Due to toxic triterpene saponins causing gastrointestinal distress and potential severe poisoning, all plant parts except properly cooked young shoots are considered unsafe. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Echinacea, Astragalus, Elderberry, Cleavers, Red Clover

Safety & Interactions

Poke root is highly toxic at all plant parts, with roots containing the highest concentrations of phytolaccatoxin and phytolaccigenin; ingestion of even small amounts (as little as a few berries in children) can cause severe vomiting, diarrhea, hypotension, respiratory depression, seizures, and death. PWM can induce non-specific immune activation and has been associated with chromosomal abnormalities in proliferating lymphocytes at high doses in laboratory settings, raising concerns about mutagenicity. Poke root is absolutely contraindicated during pregnancy and breastfeeding due to demonstrated abortifacient effects and potential transfer of toxins to infants. It should not be combined with immunosuppressant drugs (e.g., cyclosporine, corticosteroids), anticoagulants, or any lymphocyte-modulating therapies, as PWM-driven immune stimulation may unpredictably override pharmacological immunosuppression.